IGM Biosciences Inc Forecast, price target & analysts
IGM Biosciences Inc Target price 2025 - Analyst rating & recommendation
IGM Biosciences Inc Classifications & Recommendation:
IGM Biosciences Inc Price Target
| Target Price | $1.58 |
| Price | $1.21 |
| Potential |
30.85%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target IGM Biosciences Inc 2026 .
The average IGM Biosciences Inc target price is $1.58.
This is
30.85%
register free of charge
$3.00
147.93%
register free of charge
$0.75
38.02%
register free of charge
|
|
| A rating was issued by 2 analysts: 0 Analysts recommend IGM Biosciences Inc to buy, 1 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the IGM Biosciences Inc stock has an average upside potential 2026 of
30.85%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 2.68 | 9.26 |
| 25.82% | 245.40% | |
| EBITDA Margin | -6,907.09% | -913.03% |
| 42.35% | 86.78% | |
| Net Margin | -7,305.97% | -1,003.52% |
| 36.85% | 86.26% |
3 Analysts have issued a sales forecast IGM Biosciences Inc 2025 . The average IGM Biosciences Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast IGM Biosciences Inc 2025 . The average IGM Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-185m | 27.46% |
|---|---|---|
| 2025 |
$-84.5m
54.34%
Unlock
|
|
EBITDA Margin
| 2024 | -6,907.09% | 42.35% |
|---|---|---|
| 2025 |
-913.03%
86.78%
Unlock
|
|
3 IGM Biosciences Inc Analysts have issued a net profit forecast 2025. The average IGM Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -3.24 | -1.55 |
| 31.21% | 52.16% | |
| P/E | negative | |
| EV/Sales | negative |
3 Analysts have issued a IGM Biosciences Inc forecast for earnings per share. The average IGM Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
IGM Biosciences Inc...
Current IGM Biosciences Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Jun 11 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Jan 13 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jan 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jun 11 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jan 13 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
Jan 10 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jan 10 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
